Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Nestler

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|January 6, 2010
Sex hormone-binding globulin and risk of type 2 diabetesJohn E Nestler
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 31, 2003
Insulin resistance syndrome and polycystic ovary syndromeJohn E Nestler
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
Obesity, insulin, sex steroids and ovulationJ E Nestler
Seminars in Reproductive Endocrinology|May 1, 1997
Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implicationsJ E Nestler
Annals of Internal Medicine|November 1, 1986
Stimulation of androgen production by insulin-like growth factor IJ E Nestler
Endocrinology|November 1, 1987
Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor IJ E Nestler
Annals of Internal Medicine|March 1, 1981
Immunoglobulin D multiple myeloma with thrombocytosisJ E Nestler
The New England Journal of Medicine|October 6, 2016
Polycystic Ovary SyndromeJohn E Nestler
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Is metformin or clomiphene citrate more effective for ovulation induction in polycystic ovary syndrome?John E Nestler
Endocrinology|November 1, 1990
Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblastsJ E Nestler
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|January 6, 2010
Sex hormone-binding globulin and risk of type 2 diabetesJohn E Nestler
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 31, 2003
Insulin resistance syndrome and polycystic ovary syndromeJohn E Nestler
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
Obesity, insulin, sex steroids and ovulationJ E Nestler
Seminars in Reproductive Endocrinology|May 1, 1997
Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implicationsJ E Nestler
Annals of Internal Medicine|November 1, 1986
Stimulation of androgen production by insulin-like growth factor IJ E Nestler
Endocrinology|November 1, 1987
Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor IJ E Nestler
Annals of Internal Medicine|March 1, 1981
Immunoglobulin D multiple myeloma with thrombocytosisJ E Nestler
The New England Journal of Medicine|October 6, 2016
Polycystic Ovary SyndromeJohn E Nestler
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Is metformin or clomiphene citrate more effective for ovulation induction in polycystic ovary syndrome?John E Nestler
Endocrinology|November 1, 1990
Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblastsJ E Nestler
Pageof 18